Ladenburg Thalmann Financial Services’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $0 | Sell |
1
-11
| -92% | – | ﹤0.01% | 5498 |
|
|
2019
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 5165 |
|
|
2019
Q2 | $2K | Hold |
12
| – | – | ﹤0.01% | 5005 |
|
|
2019
Q1 | $2K | Hold |
12
| – | – | ﹤0.01% | 4968 |
|
|
2018
Q4 | $2K | Sell |
12
-9
| -43% | -$1.5K | ﹤0.01% | 4932 |
|
|
2018
Q3 | $13K | Hold |
21
| – | – | ﹤0.01% | 4154 |
|
|
2018
Q2 | $58K | Hold |
21
| – | – | ﹤0.01% | 3165 |
|
|
2018
Q1 | $58K | Hold |
21
| – | – | ﹤0.01% | 3165 |
|
|
2017
Q4 | $92K | Hold |
21
| – | – | ﹤0.01% | 2788 |
|
|
2017
Q3 | $169K | Buy |
21
+6
| +40% | +$48.3K | ﹤0.01% | 2231 |
|
|
2017
Q2 | $74K | Hold |
15
| – | – | ﹤0.01% | 2718 |
|
|
2017
Q1 | $83K | Buy |
15
+5
| +50% | +$27.7K | ﹤0.01% | 2527 |
|
|
2016
Q4 | $67K | Hold |
10
| – | – | ﹤0.01% | 2632 |
|
|
2016
Q3 | $148K | Hold |
10
| – | – | ﹤0.01% | 1965 |
|
|
2016
Q2 | $153K | Hold |
10
| – | – | ﹤0.01% | 1847 |
|
|
2016
Q1 | $201K | Buy |
10
+4
| +67% | +$80.4K | ﹤0.01% | 1606 |
|
|
2015
Q4 | $115K | Hold |
6
| – | – | ﹤0.01% | 1954 |
|
|
2015
Q3 | $114K | Buy |
+6
| New | +$114K | ﹤0.01% | 1888 |
|